Journal Articles
- Yuki Grace Yoshida, Su Yan, Hui Xu and Jian Yang, 2023, "Novel metal nanomaterials to promote angiogenesis in tissue regeneration", Engineered Regeneration, pp. 12
- Xinyu Tan, Ethan Gerhard, Yuqi Wang, Richard T. Tran, Hui Xu, Su Yan, Elias B. Rizk, April D. Armstrong, Yuxiao Zhou, Jing Du, Xiaochun Bai and Jian Yang, 2022, "Development of Biodegradable Osteopromotive Citrate-Based Bone Putty", Small, pp. 17
- Sarwish Rafiq, Oladapo O Yeku, Hollie J Jackson, Terence J Purdon, Dayenne G van Leeuwen, Dylan J Drakes, Mei Song, Matthew M Miele, Zhuoning Li, Pei Wang and Su Yan, 2018, "Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo", Nature Biotechnology, pp. 15
- Mahiuddin Ahmed, Andres Lopez-Albaitero, Dmitry Pankov, Brian H Santich, Hong Liu and Su Yan, 2018, "TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies", JCI Insight, pp. 16
- Hong Liu, Yiyang Xu, Jingyi Xiang, Li Long, Shan Green, Zhiyuan Yang, Bryan Zimdahl, Jingwei Lu, Neal Cheng, Lucas H Horan, Bin Liu and Su Yan, 2017, "Targeting Alpha-Fetoprotein (AFP)-MHC Complex with CAR T-Cell Therapy for Liver Cancer", Clinical Cancer Research, pp. 11
- Tao Dao, Dmitry Pankov, Andrew Scott, Tatyana Korontsvit, Victoriya Zakhaleva, Yiyang Xu, Jingyi Xiang, Su Yan and Su Yan, 2015, "Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1", Nature Biotechnology, pp. 10
- Leonid Dubrovsky, Dmitry Pankov, Elliott Brea, Tao Dao, Andrew Scott, Su andan, , 2014, "A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemias", Blood, pp. 9
- Tao Dao, Su Yan and Nicholas Veomett, 2013, "Targeting the intracellular WT1 oncogene product with a therapeutic human antibody", Science Translational Medicine, pp. 11
- Guilly Rebagay, Su Yan and Cheng Liu, 2012, "ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy", Frontier, pp. 8
